Ceribell
Highly Engaged Employees
Highly Engaged EmployeesManufacturing · California, United States · 201-500 Employees
View Company Info for Free
Overview
Headquarters
360 N Pastoria Ave, Sunnyvale, Californi...Phone Number
(800) 436-0826Website
www.ceribell.comRevenue
$95.1 MillionStock Symbol
CBLLIndustry
ZI Rank: 1
Signal Type
Feb
Mar
Apr
May
Jun
Jul
ZI Rank
1
1
1
1
1
1
About Ceribell
Ceribell is a venture-backed medical device start-up company founded in 2014 by two faculty members at Stanford University who were frustrated by the conventional EEG systems. To meet the clinical unmet needs, Ceribell has developed a point-of-care EEG system that makes the diagnosis of neurological patients drastically more efficient. Ceribell is focused on making EEG widely accessible, more efficient, and more cost-effective to improve the diagnosis and treatment of patients at risk for seizure. Weve created and validated an FDA cleared EEG system that does not require an EEG tech to do a lengthy setup or a long wait for a specialist to interpret the initial results.Explore more
Ceribell Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Ceribell your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Check out if Ceribell is spiking on competitors!
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Funding: Get notified immidiatlly once Ceribell has new funding data
Earning: See what the market has to say on Ceribell recently announced quarterly report
Check if Ceribell has recently received funding, and reach out quickly before it becomes old news!
Congratulate Masked Content for being promoted to Masked Content at Ceribell
Website visits: Recent activity has been detected on your website
Product Launch: Get notified when Ceribell launches new products
Click to see if Ceribell had a recent Job posting/layoffs
Ceribell, which may be a good buyer, showed buying intent in Masked Content Topic
Recommended Actions
Reach out to Masked Content who joined Ceribell as Masked Content
Find more new buyers
Compare Similar Companies to Ceribell
Compare insights from companies similar to Ceribell, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
Ceribell is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
Ceribell is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about Ceribell.
Ceribell financials insights
Gather financial insights about Ceribell, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2017
Series A
$13M
2018
Series B
$35M
2020
Debt
$20M
2021
Series C
$103M
Ceribell Tech Stack
A closer look at the technologies used by Ceribell
See more technologies
Most Recent Scoops
Open Position
Project
Laboratory Operations, Medical Research, Clinical Operations
Person-Based
Earnings, Finance
Open Position
Open Position
Ceribell News & Media
Ceribell Reports Second Quarter 2026 Financial Results
SUNNYVALE, Calif., Aug. 10, 2026 (GLOBE NEWSWIRE) -- CeriBell, Inc. (Nasdaq: CBLL) (“Ceribell”), a medical technology company focused on transforming the diagnosis and management of patients with serious neurological conditions, today reported financial results for the second quarter ended June 30, 2026.Ceribell Receives FDA Clearance for Advanced Epileptiform Abnormality Detection and Artifact Reduction for Its Cloud-Based Portal, Delivering Greater Precision for Critical-Care EEG Review
Neurology Review Software Enhancements Included as Part of Industry-Leading Ceribell Point-of-Care Brain Monitoring System Neurology Review Software Enhancements Included as Part of Industry-Leading Ceribell Point-of-Care Brain Monitoring SystemCeribell Secures CMS New Technology Add-On Payment (NTAP) for Breakthrough Point-of-Care Delirium Monitor System
Incremental NTAP Reimbursement Stands to Broaden Access to First-of-Its-Kind Dual Seizure and Delirium Monitoring Platform Incremental NTAP Reimbursement Stands to Broaden Access to First-of-Its-Kind Dual Seizure and Delirium Monitoring PlatformCeribell Expands Board of Directors with Appointments of Thomas West and Sharon O’Keefe
Medtech Market-Builder Thomas West and Health System Operator Sharon O’Keefe Join Ceribell as Point-of-Care Brain Monitoring Advances Toward Standard of Care Medtech Market-Builder Thomas West and Health System Operator Sharon O’Keefe Join Ceribell as Point-of-Care Brain Monitoring Advances Toward Standard of Care
Read more news
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Ceribell
Sign Up For FreeTo access detailed company insights
Ceribell is a venture-backed medical device start-up company founded in 2014 by two faculty members at Stanford University who were frustrated by the conventional EEG systems. To meet the clinical unmet needs, Ceribell has developed a point-of-care EEG system that makes the diagnosis of neurological patients drastically more efficient. Ceribell is... Read More
